@entity1962 of the liver: clinicopathologic features in 12 XXXX and review of the literature.

@entity1 @entity353 @entity1897 @entity201 @entity157 @entity1962
We present and compare the clinical features and outcomes of 12 @entity1 with primary @entity1962 (ADS- @entity201 ) of the liver who underwent hepatic resection at our institution with those of 29 cases whose surgical treatment were reported in the literature. @entity1897 ( @entity201 ) occurs @entity157 in most parts of the world. Reports of surgically treated cases of ADS- @entity201 are seen only sporadically because of the low resectability rate, difficulty in making an early diagnosis, and the poor prognosis. Furthermore, a clinicopathological study based on a certain number of surgically treated cases is still lacking. From 1977 to 2001, 12 cases of hepatic ADS- @entity201 who underwent hepatic resection were reviewed in respect to clinical features and long-term results. The clinical features and outcomes of the 29 @entity1 who underwent hepatic resection reported in the literature are also summarized for comparison. Of 228 surgically treated @entity201 @entity1 in our institute, 12 (5.3%) were ADS- @entity201 . A male predominance was observed in our study and in the reported cases. In our series, prominent body @entity353 and prominent relationship to hepatolithiasis were observed. The prognosis is dismal in @entity1 with ADS- @entity201 who undergo hepatic resection; however, there was no significant difference in overall survival between the ADS- @entity201 and @entity201 groups. In our series, the 1-, 2-, and 3-year survival rates of ADS- @entity201 and @entity201 @entity1 were 18.8%, 0%, and 0% and 32.8%, 14.8%, and 9.5%, respectively. ADS- @entity201 is prominently related to body @entity353 and hepatolithiasis in our series compared with the reported cases. The prognosis of @entity1 with ADS- @entity201 who undergo hepatic resection is dismal because of the specific biological behavior of ADS- @entity201 .
